Prefilled Syringes Global Market – Forecast To 2028

Publishing Date : June, 2022
Report Code : HCMD0174
Price:
Single license $4,950
Site license $6,750
Global license $9,000


Note: The report would be dispatched after confirmation of payment

Prefilled syringes are the immediate packaging systems or self-contained drug delivery systems that are used to encase and deliver injectable pharmaceutical products used for treating communicable and non-communicable diseases, preventing infectious diseases and enhancing the diagnostic accuracy of diagnostic procedures. These primary containers that have evolved to become the status-quo device among the pharmaceutical companies through the incorporation of proprietary features to improve administration of a therapy, clinical outcomes and regulatory claims help the firms to further protect or regain their revenue streams during the mature years of pharmaceutical products lifecycle.

As estimated by IQ4I analysis, the prefilled syringes global market is expected to grow at a high single digit CAGR to reach $10,273.8 million by 2028 due to the escalating popularity of prefillable syringes among patients and healthcare professionals, elevating propensity of pharmaceutical companies towards prefillable syringes for economical brand differentiation, preferential adoption of prefilled syringes for the delivery of various highly viscous and sensitive biologic products, emergence of technologically advanced prefillable syringe products, persistently escalating prevalence of chronic and infectious diseases and allergies, increasing number of prefillable syringes being approved by regulatory authorities across the globe and the trend of collaboration and investments among the prefillable syringe manufacturers.

The prefilled syringes global market is categorized into various market segments based on the material, design, closure system, application, product, usability, molecule type, route of administration and geography.

The prefilled syringes global market based on material is segmented into glass based prefilled syringes and polymer based prefilled syringes. Among these, glass based prefilled syringes segment commanded the largest revenue in 2021 and is expected to grow at a high single digit CAGR from 2021 to 2028. Polymer based prefilled syringes segment is the fastest emerging segment and is expected to grow at a double digit CAGR from 2021 to 2028.

The prefilled syringes global market based on design is grouped into single chamber prefilled syringes and dual chamber prefilled syringes. Among these, single chamber prefilled syringes segment commanded the largest revenue in 2021 and is expected to grow at a high single digit CAGR from 2021 to 2028. Dual chamber prefilled syringes segment is the fastest emerging segment and is expected to grow at a double digit CAGR during the forecasted period.

The prefilled syringes global market based on closure system is classified into staked needle prefilled syringes, luer lock prefilled syringes and non-luer lock prefilled syringes. Among these, staked needle prefilled syringes segment commanded the largest revenue in 2021 and is also the fastest growing segment that is expected to grow at a high single digit CAGR from 2021 to 2028.

The prefilled syringes global market based on application is categorized into heparin prefilled syringes, vaccines prefilled syringes, therapeutic drugs prefilled syringes, diluents prefilled syringes, surgical application prefilled syringes, hyaluronic acid prefilled syringes and other prefilled syringes applications (other anticoagulant prefilled syringes, saline flush prefilled syringes and contrast imaging agents prefilled syringes). Among these, heparin prefilled syringes segment commanded the largest revenue in 2021 and is expected to grow at a mid-single digit CAGR from 2021 to 2028. Therapeutic drugs prefilled syringes segment is the fastest emerging segment and is expected to grow at a low teen CAGR from 2021 to 2028.

The prefilled syringes global market based on product is divided into complete prefilled syringes, consumables (needles) and accessory devices (autoinjectors, syringe pumps, wearable injectors). Among these, complete prefilled syringes segment accounted for the largest revenue in 2021 and is expected to grow at a high single digit CAGR from 2021 to 2028. Accessory devices segment is the fastest emerging segment and is expected to grow at a high single digit CAGR from 2021 to 2028. Complete prefilled syringes segment based on product type is further segregated into conventional prefilled syringes and safety prefilled syringes. Among these, safety prefilled syringes segment accounted for the largest revenue in 2021 and is also the fastest growing segment that is expected to grow at a high single digit CAGR from 2021 to 2028.

The prefilled syringes global market based on usability is bifurcated into disposable prefilled syringes and reusable prefilled syringes. Among these, disposable prefilled syringes segment commanded the largest revenue in 2021 and is also the fastest growing segment that is expected to grow at a high single digit CAGR from 2021 to 2028.

The prefilled syringes global market based on molecule type is segmented into large molecule prefilled syringes and small molecule prefilled syringes. Among these, large molecule prefilled syringes segment accounted for the largest revenue in 2021 and is also the fastest emerging segment that is expected to grow at a high single digit CAGR from 2021 to 2028.

The prefilled syringes global market based on route of administration is segregated into subcutaneous prefilled syringes, intramuscular prefilled syringes, intravenous prefilled syringes and other routes prefilled syringes (intra-articular prefilled syringes, intra-vitreal prefilled syringes, topical prefilled syringes). Among these, subcutaneous prefilled syringes segment accounted for the largest revenue in 2021 and is also the fastest growing segment that is expected to grow at a high single digit CAGR from 2021 to 2028.

The report provides an in-depth market analysis of the above-mentioned segments across the following regions:

  • North America
  • U.S.
  • Rest of North America
  • Europe
  • Germany
  • France
  • Italy
  • Rest of Europe
  • Asia-Pacific 
  • China
  • Japan
  • India
  • Rest of APAC
  • Rest of the World (RoW)
  • Brazil
  • Rest of LATAM
  • Middle East and Africa (MEA)
  • 1     EXECUTIVE SUMMARY
  • 2     INTRODUCTION
    • 2.1     KEY TAKEAWAYS
    • 2.2     SCOPE OF THE REPORT
    • 2.3     REPORT DESCRIPTION
    • 2.4     MARKETS COVERED
    • 2.5     STAKEHOLDERS
    • 2.6     RESEARCH METHODOLOGY
      • 2.6.1     MARKET SIZE ESTIMATION
      • 2.6.2     MARKET BREAKDOWN AND DATA TRIANGULATION
      • 2.6.3     SECONDARY SOURCES
      • 2.6.4     PRIMARY SOURCES
      • 2.6.5     KEY DATA POINTS FROM SECONDARY SOURCES
      • 2.6.6     KEY DATA POINTS FROM PRIMARY SOURCES
      • 2.6.7     ASSUMPTIONS
      • 2.6.8     AVERAGE SELLING PRICE (ASP) OF PREFILLED SYRINGES AND HEPARIN PREFILLED SYRINGES, (2021) ($)
  • 3     MARKET ANALYSIS
    • 3.1     INTRODUCTION
    • 3.2     MARKET SEGMENTATION
    • 3.3     FACTORS INFLUENCING MARKET
      • 3.3.1     DRIVERS AND OPPORTUNITIES
        • 3.3.1.1     Increasing popularity of Prefilled Syringes among patients and healthcare professionals
        • 3.3.1.2     Increasing inclination of pharmaceutical companies towards prefilled syringes for injectable drug product cost-savings and brand differentiation
        • 3.3.1.3     Preferential adoption of prefilled syringes for the delivery of biologics
        • 3.3.1.4     Emergence of technologically advanced products
        • 3.3.1.5     Escalating prevalence of Chronic and Infectious diseases and Allergies
        • 3.3.1.6     Increasing regulatory approvals of prefilled syringes
        • 3.3.1.7     Collaborations and Investments to open an array of opportunities for the market to flourish
      • 3.3.2     RESTRAINTS AND THREATS
        • 3.3.2.1     Technical challenges associated with manufacturing process of prefillable syringes
        • 3.3.2.2     Increasing concerns about the interaction of prefillable syringe components with drug products
        • 3.3.2.3     Availability of less expensive and non-invasive medication alternatives
        • 3.3.2.4     Stringent international standards and regulatory guidelines to followed by prefillable syringe manufacturers
        • 3.3.2.5     Threat of Recalls of Prefilled Syringes
    • 3.4     REGULATORY AFFAIRS
      • 3.4.1     INTERNATIONAL ORGANIZATION FOR STANDARDIZATION
        • 3.4.1.1     ISO 11040-4:2015 (PART 4): GLASS BARRELS FOR INJECTABLES AND STERILIZED SUBASSEMBLED SYRINGES READY FOR FILLING
        • 3.4.1.2     ISO 11040-5:2012 (PART 5): PLUNGER STOPPERS FOR INJECTABLES
        • 3.4.1.3     ISO 11040-6:2019 (PART 6): PLASTIC BARRELS FOR INJECTABLES AND STERILIZED SUBASSEMBLED SYRINGES READY FOR FILLING
        • 3.4.1.4     ISO 23908:2011: SHARPS PROTECTION FEATURES FOR SINGLE-USE HYPODERMIC NEEDLES, INTRODUCERS FOR CATHETERS AND NEEDLES USED FOR BLOOD SAMPLING
        • 3.4.1.5     ISO 80369-20:2015: SMALL-BORE CONNECTORS FOR LIQUIDS AND GASES IN HEALTHCARE APPLICATIONS
      • 3.4.2     U.S.
      • 3.4.3     CANADA
      • 3.4.4     EUROPE
      • 3.4.5     JAPAN
      • 3.4.6     CHINA
      • 3.4.7     INDIA
    • 3.5     PORTER’S FIVE FORCE ANALYSIS
      • 3.5.1     THREAT OF NEW ENTRANTS
      • 3.5.2     THREAT OF SUBSTITUTES
      • 3.5.3     BARGAINING POWER OF SUPPLIERS
      • 3.5.4     BARGAINING POWER OF BUYERS
      • 3.5.5     COMPETITIVE RIVALRY
    • 3.6     SUPPLY CHAIN ANALYSIS
    • 3.7     TECHNOLOGICAL ADVANCEMENTS
      • 3.7.1     INTRODUCTION
      • 3.7.2     PREFILLABLE SYRINGES FOR DEEP COLD STORAGE OF VACCINES
      • 3.7.3     REUSABLE OR MULTIDOSE PREFILLABLE SYRINGES
      • 3.7.4     TABLET-IN-SYRINGE
    • 3.8     PATENT TRENDS
    • 3.9     CLINICAL TRIALS
    • 3.10     SALES VOLUME OR NUMBER OF UNITS OF PREFILLED SYRINGES
      • 3.10.1     PREFILLED SYRINGES NUMBER OF UNITS BASED ON REGION AND COUNTRY
      • 3.10.2     HEPARIN PREFILLED SYRINGES NUMBER OF UNITS BASED ON REGION AND COUNTRY
    • 3.11     IMPACT OF COVID-19 ON PREFILLED SYRINGES
    • 3.12     MARKET SHARE ANALYSIS BASED ON MAJOR PLAYERS
      • 3.12.1     PREFILLED SYRINGES GLOBAL MARKET SHARE ANALYSIS
    • 3.13     PREFILLED SYRINGES COMPANY COMPARISON TABLE BY REVENUE, PRODUCT AND PRODUCT PRODUCT TYPE
  • 4     PREFILLED SYRINGES GLOBAL MARKET, BASED ON MATERIAL
    • 4.1     INTRODUCTION
    • 4.2     GLASS BASED PREFILLED SYRINGES
    • 4.3     POLYMER BASED PREFILLED SYRINGES
  • 5     PREFILLED SYRINGES GLOBAL MARKET, BASED ON DESIGN
    • 5.1     INTRODUCTION
    • 5.2     SINGLE CHAMBER PREFILLED SYRINGES
    • 5.3     DUAL CHAMBER PREFILLED SYRINGES
  • 6     PREFILLED SYRINGS GLOBAL MARKET, BASED ON CLOSURE SYSTEM
    • 6.1     INTRODUCTION
    • 6.2     STAKED NEEDLE PREFILLED SYRINGES
    • 6.3     LUER LOCK PREFILLED SYRINGES
    • 6.4     NON-LUER LOCK PREFILLED SYRINGES
  • 7     PREFILLED SYRINGES GLOBAL MARKET, BASED ON PRODUCT
    • 7.1     INTRODUCTION
    • 7.2     COMPLETE PREFILLED SYRINGES
      • 7.2.1     CONVENTIONAL PREFILLED SYRINGES
      • 7.2.2     SAFETY PREFILLED SYRINGES
    • 7.3     CONSUMABLES (NEEDLES)
    • 7.4     ACCESSORY DEVICES (AUTOINJECTORS, WEARABLE INJECTORS AND SYRINGE PUMPS)
  • 8     PREFILLED SYRINGES GLOBAL MARKET, BASED ON APPLICATION
    • 8.1     INTRODUCTION
    • 8.2     HEPARIN PREFILLED SYRINGES
    • 8.3     VACCINES PREFILLED SYRINGES
    • 8.4     THERAPEUTIC DRUGS PREFILLED SYRINGES
    • 8.5     DILUENTS PREFILLED SYRINGES
    • 8.6     SURGICAL APPLICATION (ANAESTHETIC AGENTS, SURGICAL SEALANTS) PREFILLED SYRINGES
    • 8.7     HYALURONIC ACID PREFILLED SYRINGES
    • 8.8     OTHER PREFILLED SYRINGE APPLICATIONS (OTHER ANTICOAGULANT PREFILLED SYRINGES, SALINE FLUSH PREFILLED SYRINGES AND CONTRAST IMAGING AGENTS PREFILLED SYRINGES)
  • 9     PREFILLED SYRINGES GLOBAL MARKET, BASED ON USABILITY
    • 9.1     INTRODUCTION
    • 9.2     DISPOSABLE PREFILLED SYRINGES
    • 9.3     REUSABLE PREFILLED SYRINGES
  • 10     PREFILLED SYRINGES GLOBAL MARKET, BASED ON MOLECULE TYPE
    • 10.1     INTRODUCTION
    • 10.2     LARGE MOLECULE PREFILLED SYRINGES
    • 10.3     SMALL MOLECULE PREFILLED SYRINGES
  • 11     PREFILLED SYRINGES GLOBAL MARKET BASED ON ROUTE OF ADMINISTRATION
    • 11.1     INTRODUCTION
    • 11.2     SUBCUTANEOUS PREFILLED SYRINGES
    • 11.3     INTRAMUSCULAR PREFILLED SYRINGES
    • 11.4     INTRAVENOUS PREFILLED SYRINGES
    • 11.5     OTHER ROUTES PREFILLED SYRINGES (INTRA-ARTICULAR PREFILLED SYRINGES, TOPICAL PREFILLED SYRINGES, INTRA-VITREAL PREFILLED SYRINGES)
  • 12     REGIONAL ANALYSIS
    • 12.1     INTRODUCTION
    • 12.2     NORTH AMERICA
      • 12.2.1     U.S.
      • 12.2.2     REST OF NORTH AMERICA
    • 12.3     EUROPE
      • 12.3.1     GERMANY
      • 12.3.2     ITALY
      • 12.3.3     FRANCE
      • 12.3.4     REST OF EUROPE
    • 12.4     ASIA-PACIFIC
      • 12.4.1     CHINA
      • 12.4.2     JAPAN
      • 12.4.3     INDIA
      • 12.4.4     REST OF APAC
    • 12.5     REST OF THE WORLD
      • 12.5.1     BRAZIL
      • 12.5.2     REST OF LATIN AMERICA (LATAM)
      • 12.5.3     MIDDLE EAST AND AFRICA (MEA)
  • 13     COMPETITIVE LANDSCAPE
    • 13.1     INTRODUCTION
    • 13.2     PRODUCT LAUNCH
    • 13.3     EXPANSION
    • 13.4     COLLABORATION
    • 13.5     INVESTMENT
    • 13.6     OTHER DEVELOPMENTS
  • 14     MAJOR COMPANIES
    • 14.1     BECTON, DICKINSON AND COMPANY
      • 14.1.1     OVERVIEW
      • 14.1.2     FINANCIALS
      • 14.1.3     PRODUCT PORTFOLIO
      • 14.1.4     KEY DEVELOPMENTS
      • 14.1.5     BUSINESS STRATEGY
      • 14.1.6     SWOT ANALYSIS
    • 14.2     ELCAM MEDICAL
      • 14.2.1     OVERVIEW
      • 14.2.2     FINANCIALS
      • 14.2.3     PRODUCT PORTFOLIO
      • 14.2.4     KEY DEVELOPMENTS
      • 14.2.5     BUSINESS STRATEGY
      • 14.2.6     SWOT ANALYSIS
    • 14.3     GERRESHEIMER AG
      • 14.3.1     OVERVIEW
      • 14.3.2     FINANCIALS
      • 14.3.3     PRODUCT PORTFOLIO
      • 14.3.4     KEY DEVELOPMENTS
      • 14.3.5     BUSINESS STRATEGY
      • 14.3.6     SWOT ANALYSIS
    • 14.4     NIPRO CORPORATION
      • 14.4.1     OVERVIEW
      • 14.4.2     FINANCIALS
      • 14.4.3     PRODUCT PORTFOLIO
      • 14.4.4     KEY DEVELOPMENTS
      • 14.4.5     BUSINESS STRATEGY
      • 14.4.6     SWOT ANALYSIS
    • 14.5     OWEN MUMFORD LTD
      • 14.5.1     OVERVIEW
      • 14.5.2     FINANCIALS
      • 14.5.3     PRODUCT PORTFOLIO
      • 14.5.4     KEY DEVELOPMENTS
      • 14.5.5     BUSINESS STRATEGY
      • 14.5.6     SWOT ANALYSIS
    • 14.6     SCHOTT AG
      • 14.6.1     OVERVIEW
      • 14.6.2     FINANCIALS
      • 14.6.3     PRODUCT PORTFOLIO
      • 14.6.4     KEY DEVELOPMENTS
      • 14.6.5     BUSINESS STRATEGY
      • 14.6.6     SWOT ANALYSIS
    • 14.7     SHANDONG WEIGAO GROUP MEDICAL POLYMER COMPANY LIMITED
      • 14.7.1     OVERVIEW
      • 14.7.2     FINANCIALS
      • 14.7.3     PRODUCT PORTFOLIO
      • 14.7.4     KEY DEVELOPMENTS
      • 14.7.5     BUSINESS STRATEGY
      • 14.7.6     SWOT ANALYSIS
    • 14.8     STEVANATO GROUP S.P.A.
      • 14.8.1     OVERVIEW
      • 14.8.2     FINANCIALS
      • 14.8.3     PRODUCT PORTFOLIO
      • 14.8.4     KEY DEVELOPMENTS
      • 14.8.5     BUSINESS STRATEGY
      • 14.8.6     SWOT ANALYSIS
    • 14.9     TERUMO CORPORATION
      • 14.9.1     OVERVIEW
      • 14.9.2     FINANCIALS
      • 14.9.3     PRODUCT PORTFOLIO
      • 14.9.4     KEY DEVELOPMENTS
      • 14.9.5     BUSINESS STRATEGY
      • 14.9.6     SWOT ANALYSIS
    • 14.10     YPSOMED HOLDING AG
      • 14.10.1     OVERVIEW
      • 14.10.2     FINANCIALS
      • 14.10.3     PRODUCT PORTFOLIO
      • 14.10.4     KEY DEVELOPMENTS
      • 14.10.5     BUSINESS STRATEGY
      • 14.10.6     SWOT ANALYSIS

      LIST OF TABLES

      • TABLE 1     PREFILLED SYRINGES GLOBAL MARKET REVENUE, BASED ON REGION, (2020-2028) ($MN)
      • TABLE 2     PREFILLED SYRINGES NUMBER OF UNITS, BASED ON REGION, (2020-2028) (NO'S)
      • TABLE 3     HEPARIN PREFILLED SYRINGES NUMBER OF UNITS, BASED ON REGION, (2020 - 2028) (NO'S)
      • TABLE 4     PREFILLED SYRINGES GLOBAL MARKET REVENUE, BASED ON MATERIAL, (2020-2028) ($MN)
      • TABLE 5     GLASS BASED PREFILLED SYRINGES GLOBAL MARKET REVENUE, BASED ON REGION, (2020-2028) ($MN)
      • TABLE 6     POLYMER BASED PREFILLED SYRINGS GLOBAL MARKET REVENUE, BASED ON REGION, (2020-2028) ($MN)
      • TABLE 7     PREFILLED SYRINGES GLOBAL MARKET REVENUE, BASED ON DESIGN, (2020-2028) ($MN)
      • TABLE 8     SINGLE CHAMBER PREFILLED SYRINGS GLOBAL MARKET REVENUE, BASED ON REGION, (2020-2028) ($MN)
      • TABLE 9     DUAL CHAMBER PREFILLED SYRINGES GLOBAL MARKET REVENUE, BASED ON REGION, (2020-2028) ($MN)
      • TABLE 10     PREFILLED SYRINGS GLOBAL MARKET REVENUE, BASED ON CLOSURE SYSTEM, (2020-2028) ($MN)
      • TABLE 11     STAKED NEEDLE PREFILLED SYRINGES GLOBAL MARKET REVENUE, BASED ON REGION, (2020-2028) ($MN)
      • TABLE 12     LUER LOCK PREFILLED SYRINGES GLOBAL MARKET REVENUE, BASED ON REGION, (2020-2028) ($MN)
      • TABLE 13     NON LUER-LOCK PREFILLED SYRINGES GLOBAL MARKET REVENUE, BASED ON REGION, (2020-2028) ($MN)
      • TABLE 14     PREFILLED SYRINGES GLOBAL MARKET REVENUE, BASED ON PRODUCT, (2020-2028) ($MN)
      • TABLE 15     COMPLETE PREFILLED SYRINGES GLOBAL MARKET REVENUE, BASED ON PRODUCT, (2020-2028) ($MN)
      • TABLE 16     CONVENTIONAL PREFILLED SYRINGES GLOBAL MARKET REVENUE, BASED ON REGION, (2020-2028) ($MN)
      • TABLE 17     SAFETY PREFILLED SYRINGES GLOBAL MARKET REVENUE, BASED ON REGION, (2020-2028) ($MN)
      • TABLE 18     CONSUMABLES GLOBAL MARKET REVENUE, BY REGION, (2020-2028) ($MN)
      • TABLE 19     ACCESSORY DEVICES GLOBAL MARKET REVENUE, BASED ON REGION, (2020-2028) ($MN)
      • TABLE 20     PREFILLED SYRINGES GLOBAL MARKET REVENUE, BASED ON APPLICATION, (2020-2028) ($MN)
      • TABLE 21     HEPARIN PREFILLED SYRINGES GLOBAL MARKET REVENUE, BASED ON REGION, (2020-2028) ($MN)
      • TABLE 22     VACCINES PREFILLED SYRINGES GLOBAL MARKET REVENUE, BASED ON REGION, (2020-2028) ($MN)
      • TABLE 23     THERAPEUTIC DRUGS PREFILLED SYRINGES GLOBAL MARKET REVENUE, BASED ON REGION, (2020-2028) ($MN)
      • TABLE 24     DILUENTS PREFILLED SYRINGES GLOBAL MARKET REVENUE, BASED ON REGION, (2020-2028) ($MN)
      • TABLE 25     SURGICAL APPLICATION PREFILLED SYRINGES GLOBAL MARKET REVENUE, BASED ON REGION, (2020-2028) ($MN)
      • TABLE 26     HYALURONIC ACID PREFILLED SYRINGES GLOBAL MARKET REVENUE, BASED ON REGION, (2020-2028) ($MN)
      • TABLE 27     OTHER APPLICATIONS PREFILLED SYRINGES GLOBAL MARKET REVENUE, BASED ON REGION, (2020-2028) ($MN)
      • TABLE 28     PREFILLED SYRINGES GLOBAL MARKET REVENUE, BASED ON USABILITY, (2020-2028) ($MN)
      • TABLE 29     DISPOSABLE PREFILLED SYRINGES GLOBAL MARKET REVENUE, BASED ON REGION, (2020-2028) ($MN)
      • TABLE 30     RESUABLE PREFILLED SYRINGES GLOBAL MARKET REVENUE, BASED ON REGION, (2020-2028) ($MN)
      • TABLE 31     PREFILLED SYRINGES GLOBAL MARKET REVENUE, BASED ON MOLECULE TYPE, (2020-2028) ($MN)
      • TABLE 32     LARGE MOLECULE PREFILLED SYRINGES GLOBAL MARKET REVENUE, BASED ON REGION, (2020-2028) ($MN)
      • TABLE 33     SMALL MOLECULE PREFILLED SYRINGES GLOBAL MARKET REVENUE, BASED ON REGION, (2020-2028) ($MN)
      • TABLE 34     PREFILLED SYRINGES GLOBAL MARKET REVENUE, BASED ON ROUTE OF ADMINISTRATION, (2020-2028) ($MN)
      • TABLE 35     SUBCUTANEOUS PREFILLED SYRINGES GLOBAL MARKET REVENUE, BASED ON REGION, (2020-2028) ($MN)
      • TABLE 36     INTRAMUSCULAR PREFILLED SYRINGES GLOBAL MARKET REVENUE, BASED ON REGION, (2020-2028) ($MN)
      • TABLE 37     INTRAVENOUS PREFILLED SYRINGES GLOBAL MARKET REVENUE, BASED ON REGION, (2020-2028) ($MN)
      • TABLE 38     OTHER ROUTES PREFILLED SYRINGES GLOBAL MARKET REVENUE, BASED ON REGION, (2020-2028) ($MN)
      • TABLE 39     PREFILLED SYRINGES GLOBAL MARKET REVENUE, BASED ON REGION, (2020-2028) ($MN)
      • TABLE 40     NORTH AMERICA PREFILLED SYRINGES MARKET REVENUE, BASED ON MATERIAL, (2020-2028) ($MN)
      • TABLE 41     NORTH AMERICA PREFILLED SYRINGES MARKET REVENUE, BASED ON DESIGN, (2020-2028) ($MN)
      • TABLE 42     NORTH AMERICA PREFILLED SYRINGES MARKET REVENUE, BASED ON CLOSURE SYSTEM, (2020-2028) ($MN)
      • TABLE 43     NORTH AMERICA PREFILLED SYRINGES GLOBAL MARKET REVENUE, BASED ON APPLICATION, (2020-2028) ($MN)
      • TABLE 44     NORTH AMERICA PREFILLED SYRINGES MARKET REVENUE, BASED ON PRODUCT, (2020-2028) ($MN)
      • TABLE 45     NORTH AMERICA COMPLETE PREFILLED SYRINGES MARKET REVENUE, BASED ON PRODUCT, (2020-2028) ($MN)
      • TABLE 46     NORTH AMERICA PREFILLED SYRINGES MARKET REVENUE, BASED ON USABILITY, (2020-2028) ($MN)
      • TABLE 47     NORTH AMERICA PREFILLED SYRINGES MARKET REVENUE, BASED ON MOLECULE TYPE, (2020-2028) ($MN)
      • TABLE 48     NORTH AMERICA PREFILLED SYRINGES MARKET REVENUE, BASED ON ROUTE OF ADMINISTRATION, (2020-2028) ($MN)
      • TABLE 49     NORTH AMERICA PREFILLED SYRINGES MARKET REVENUE, BASED ON COUNTRY, (2020-2028) ($MN)
      • TABLE 50     EUROPE PREFILLED SYRINGES MARKET REVENUE, BASED ON MATERIAL, (2020-2028) ($MN)
      • TABLE 51     EUROPE PREFILLED SYRINGES MARKET REVENUE, BASED ON DESIGN, (2020-2028) ($MN)
      • TABLE 52     EUROPE PREFILLED SYRINGES MARKET REVENUE, BASED ON CLOSURE SYSTEM, (2020-2028) ($MN)
      • TABLE 53     EUROPE PREFILLED SYRINGES MARKET REVENUE, BASED ON APPLICATION, (2020-2028) ($MN)
      • TABLE 54     EUROPE PREFILLED SYRINGES MARKET REVENUE, BASED ON PRODUCT, (2020-2028) ($MN)
      • TABLE 55     EUROPE COMPLETE PREFILLED SYRINGES MARKET REVENUE, BASED ON PRODUCT, (2020-2028) ($MN)
      • TABLE 56     EUROPE PREFILLED SYRINGES MARKET REVENUE, BASED ON USABILITY, (2020-2028) ($MN)
      • TABLE 57     EUROPE PREFILLED SYRINGES MARKET REVENUE, BASED ON MOLECULE TYPE, (2020-2028) ($MN)
      • TABLE 58     EUROPE PREFILLED SYRINGES MARKET REVENUE, BASED ON ROUTE OF ADMINISTRATION, (2020-2028) ($MN)
      • TABLE 59     EUROPE PREFILLED SYRINGES MARKET REVENUE, BASED ON COUNTRY, (2020-2028) ($MN)
      • TABLE 60     APAC PREFILLED SYRINGES MARKET REVENUE, BASED ON MATERIAL, (2020-2028) ($MN)
      • TABLE 61     APAC PREFILLED SYRINGES MARKET REVENUE, BASED ON DESIGN, (2020-2028) ($MN)
      • TABLE 62     APAC PREFILLED SYRINGES MARKET REVENUE, BASED ON CLOSURE SYSTEM, (2020-2028) ($MN)
      • TABLE 63     APAC PREFILLED SYRINGES MARKET REVENUE, BASED ON APPLICATION, (2020-2028) ($MN)
      • TABLE 64     APAC PREFILLED SYRINGES MARKET REVENUE, BASED ON PRODUCT, (2020-2028) ($MN)
      • TABLE 65     APAC COMPLETE PREFILLED SYRINGES MARKET REVENUE, BASED ON PRODUCT TYPE, (2020-2028) ($MN)
      • TABLE 66     APAC PREFILLED SYRINGES MARKET REVENUE, BASED ON USABILITY, (2020-2028) ($MN)
      • TABLE 67     APAC PREFILLED SYRINGES MARKET REVENUE, BASED ON MOLECULE TYPE, (2020-2028) ($MN)
      • TABLE 68     APAC PREFILLED SYRINGES MARKET REVENUE, BASED ON ROUTE OF ADMINISTRATION, (2020-2028) ($MN)
      • TABLE 69     APAC PREFILLED SYRINGES MARKET REVENUE, BASED ON COUNTRY, (2020-2028) ($MN)
      • TABLE 70     ROW PREFILLED SYRINGES MARKET REVENUE, BASED ON MATERIAL, (2020-2028) ($MN)
      • TABLE 71     ROW PREFILLED SYRINGES MARKET REVENUE, BASED ON DESIGN, (2020-2028) ($MN)
      • TABLE 72     ROW PREFILLED SYRINGES MARKET REVENUE, BASED ON CLOSURE SYSTEM, (2020-2028) ($MN)
      • TABLE 73     ROW PREFILLED SYRINGES MARKET REVENUE, BASED ON APPLICATION, (2020-2028) ($MN)
      • TABLE 74     ROW PREFILLED SYRINGES MARKET REVENUE, BASED ON PRODUCT, (2020-2028) ($MN)
      • TABLE 75     ROW COMPLETE PREFILLED SYRINGES MARKET REVENUE, BASED ON PRODUCT TYPE, (2020-2028) ($MN)
      • TABLE 76     ROW PREFILLED SYRINGES MARKET REVENUE, BASED ON USABILITY, (2020-2028) ($MN)
      • TABLE 77     ROW PREFILLED SYRINGES MARKET REVENUE, BASED ON MOLECULE TYPE, (2020-2028) ($MN)
      • TABLE 78     ROW PREFILLED SYRINGES MARKET REVENUE, BASED ON ROUTE OF ADMINISTRATION, (2020-2028) ($MN)
      • TABLE 79     ROW PREFILLED SYRINGES MARKET REVENUE, BASED ON COUNTRY, (2020-2028) ($MN)
      • TABLE 80     PRODUCT LAUNCH (2020 - 2022)
      • TABLE 81     EXPANSION (2020 - 2022)
      • TABLE 82     COLLABORATION (2020 - 2022)
      • TABLE 83     INVESTMENT (2020 - 2022)
      • TABLE 84     OTHER DEVELOPMENTS (2020 - 2022)
      • TABLE 85     BECTON, DICKINSON AND COMPANY.: TOTAL REVENUE AND R&D EXPENSES, (2020-2022) (Q1) ($MN)
      • TABLE 86     BECTON, DICKINSON AND COMPANY.: TOTAL REVENUE, BASED ON SEGMENTS, (2020-2022) (Q1) ($MN)
      • TABLE 87     BECTON, DICKINSON AND COMPANY.: MEDICAL SEGMENT REVENUE, BASED ON SUB-SEGMENTS, (2020-2022) (Q1) ($MN)
      • TABLE 88     BECTON, DICKINSON AND COMPANY.: TOTAL REVENUE, BASED ON GEOGRAPHY (2020-2022) (Q1) ($MN)
      • TABLE 89     GERRESHEIMER AG.: TOTAL REVENUE AND R&D EXPENSES, (2020-2022) (Q1) ($MN)
      • TABLE 90     GERRESHEIMER AG.: TOTAL REVENUE, BASED ON SEGMENTS, (2020-2022) (Q1) ($MN)
      • TABLE 91     GERRESHEIMER AG.: TOTAL REVENUE, BASED ON REGION, (2020-2022) (Q1) ($MN)
      • TABLE 92     NIPRO CORPORATION: TOTAL REVENUE AND R&D EXPENSES, (2019-2021) (Q3) ($MN)
      • TABLE 93     NIPRO CORPORATION: TOTAL REVENUE, BASED ON SEGMENTS, (2019-2021) (Q3) ($MN)
      • TABLE 94     NIPRO CORPORATION: TOTAL REVENUE, BASED ON GEOGRAPHY, (2019-2021) (Q3) ($MN)
      • TABLE 95     SCHOTT A G.: TOTAL REVENUE AND R&D EXPENSES, (2019-2021) ($MN)
      • TABLE 96     SCHOTT AG.: TOTAL REVENUE, BASED ON SEGMENTS, (2019-2021) ($MN)
      • TABLE 97     SCHOTT AG.: TOTAL REVENUE, BASED ON GEOGRAPHY, (2019-2021) ($MN)
      • TABLE 98     SHANDONG WEIGAO GROUP MEDICAL POLYMER COMPANY LIMITED.: TOTAL REVENUE AND R&D EXPENSES, (2019-2021) ($MN)
      • TABLE 99     SHANDONG WEIGAO GROUP MEDICAL POLYMER COMPANY LIMITED.: TOTAL REVENUE, BASED ON SEGMENT, (2019-2021) ($MN)
      • TABLE 100     SHANDONG WEIGAO GROUP MEDICAL POLYMER COMPANY LIMITED.: TOTAL REVENUE, BASED ON REGION, (2019-2021) ($MN)
      • TABLE 101     STEVANATO GROUP S.P.A.: TOTAL REVENUE AND R&D EXPENSES, (2020-2022) (Q1) ($MN)
      • TABLE 102     STEVANATO GROUP S.P.A.: TOTAL REVENUE, BASED ON SEGMENTS, (2020-2022) (Q1) ($MN)
      • TABLE 103     STEVANATO GROUP S.P.A.: BIOPHARMACEUTICAL AND DIAGNOSTIC SOLUTIONS REVENUE, BASED ON SUB-SEGMENTS (2020-2022) (Q1) ($MN)
      • TABLE 104     STEVANATO GROUP S.P.A.: TOTAL REVENUE, BASED ON REGION, (2020-2022) (Q1) ($MN)
      • TABLE 105     TERUMO CORPORATION.: TOTAL SALES AND R&D EXPENSES, (2019-2021) ($MN)
      • TABLE 106     TERUMO CORPORATION.: TOTAL SALES, BASED ON SEGMENTS, (2019-2021) ($MN)
      • TABLE 107     TERUMO CORPORATION.: TOTAL SALES, BASED ON GEOGRAPHY, (2019-2021) ($MN)
      • TABLE 108     YPSOMED HOLDINGS AG.: TOTAL REVENUE AND R&D EXPENSES, (2019-2021) (Q2) ($MN)
      • TABLE 109     YPSOMED HOLDINGS AG.: TOTAL REVENUE, BASED ON SEGMENTS, (2019-2021) (Q2) ($MN)
      • TABLE 110     YPSOMED HOLDINGS AG.: TOTAL REVENUE, BASED ON GEOGRAPHY, (2019-2021) (Q2) ($MN)

      LIST OF FIGURES

      • FIGURE 1     PREFILLED SYRINGES GLOBAL MARKET REVENUE AND SHARE, BASED ON REGION (2020-2028) ($MN) AND 2021 (%)
      • FIGURE 2     RESEARCH METHODOLOGY: PREFILLED SYRINGES GLOBAL MARKET
      • FIGURE 3     PREFILLED SYRINGES GLOBAL MARKET: TOP-DOWN AND BOTTOM-UP APPROACH
      • FIGURE 4     PREFILLED SYRINGES GLOBAL MARKET: FORECASTING MODEL
      • FIGURE 5     PREFILLED SYRINGES GLOBAL MARKET: MARKET BREAKDOWN AND DATA TRIANGULATION
      • FIGURE 6     PREFILLED SYRINGES GLOBAL MARKET SEGMENTATION
      • FIGURE 7     MARKET DYNAMICS
      • FIGURE 8     PREFILLED SYRINGES GLOBAL MARKET: PORTER’S ANALYSIS
      • FIGURE 9     PREFILLED SYRINGES : SUPPLY CHAIN ANALYSIS
      • FIGURE 10     PREFILLED SYRINGES GLOBAL MARKET: PATENT FILING BY MAJOR PLAYERS (2017-2022)
      • FIGURE 11     PREFILLED SYRINGES CLINICAL TRIAL ANALYSIS
      • FIGURE 12     PREFILLED SYRINGES NUMBER OF UNITS, BASED ON REGION AND COUNTRY, (2021) (NO’S)
      • FIGURE 13     PREFILLED SYRINGES NUMBER OF UNITS, BASED ON COUNTRY, (2021 VS 2028) (MN)
      • FIGURE 14     HEPARIN PREFILLED SYRINGES NUMBER OF UNITS, BASED ON REGION AND COUNTRY, (2021) (NO’S)
      • FIGURE 15     HEPARIN PREFILLED SYRINGES NUMBER OF UNITS, BASED ON COUNTRY, (2021 VS 2028) (MN)
      • FIGURE 16     PREFILLED SYRINGES GLOBAL MARKET SHARE ANALYSIS, BASED ON KEY PLAYERS, 2021 (%)
      • FIGURE 17     PREFILLED SYRINGES GLOBAL MARKET SHARE, BASED ON MATERIAL (2021 V/S 2028) (%)
      • FIGURE 18     GLASS PREFILLED SYRINGES GLOBAL MARKET SHARE, BASED ON REGION (2021 V/S 2028) (%)
      • FIGURE 19     POLYMER BASED PREFILLED SYRINGES GLOBAL MARKET SHARE, BASED ON REGION (2021 V/S 2028) (%)
      • FIGURE 20     PREFILLED SYRINGES GLOBAL MARKET SHARE, BASED ON DESIGN, (2021 V/S 2028) (%)
      • FIGURE 21     PREFILLED SYRINGES GLOBAL MARKET SHARE, BASED ON CLOSURE SYSTEM (2021 V/S 2028) (%)
      • FIGURE 22     STAKED NEEDLE PREFILLED SYRINGES GLOBAL MARKET SHARE, BASED ON REGION (2021 V/S 2028) (%)
      • FIGURE 23     PREFILLED SYRINGES GLOBAL MARKET SHARE, BASED ON PRODUCT, (2021 V/S 2028) (%)
      • FIGURE 24     COMPLETE PREFILLED SYRINGES GLOBAL MARKET SHARE, BASED ON PRODUCT TYPE (2021 V/S 2028) (%)
      • FIGURE 25     COMPLETE PREFILLED SYRINGES GLOBAL MARKET SHARE, BASED ON REGION (2021 V/S 2028) (%)
      • FIGURE 26     CONVENTIONAL PREFILLED SYRINGES GLOBAL MARKET SHARE, BASED ON REGION (2021 V/S 2028) (%)
      • FIGURE 27     SAFETY DEVICES PREFILLED SYRINGES GLOBAL MARKET SHARE, BASED ON REGION (2021 V/S 2028) (%)
      • FIGURE 28     PREFILLED SYRINGES GLOBAL MARKET SHARE, BASED ON APPLICATION (2021) (%), CAGR (%)
      • FIGURE 29     VACCINES PREFILLED SYRINGES GLOBAL MARKET SHARE, BASED ON REGION (2021 V/S 2028) (%)
      • FIGURE 30     PREFILLED SYRINGES GLOBAL MARKET SHARE, BASED ON USABILITY (2021 V/S 2028) (%)
      • FIGURE 31     DISPOSABLE PREFILLED SYRINGES GLOBAL MARKET SHARE, BASED ON REGION (2021 V/S 2028) (%)
      • FIGURE 32     PREFILLED SYRINGES GLOBAL MARKET SHARE, BASED ON MOLECULE TYPE (2021 V/S 2028) (%)
      • FIGURE 33     LARGE MOLECULE PREFILLED SYRINGES GLOBAL MARKET SHARE, BASED ON REGION (2021 V/S 2028) (%)
      • FIGURE 34     PREFILLED SYRINGES GLOBAL MARKET SHARE, BASED ON ROUTE OF ADMINISTRATION (2021 V/S 2028) (%)
      • FIGURE 35     PREFILLED SYRINGES GLOBAL MARKET REVENUE, BASED ON REGION (2020-2028) ($MN)
      • FIGURE 36     PREFILLED SYRINGES GLOBAL MARKET REVENUE, BASED ON REGION AND COUNTRY (2021) ($MN)
      • FIGURE 37     NORTH AMERICA PREFILLED SYRINGES MARKET SHARE, BASED ON MATERIAL (2021 V/S 2028) (%)
      • FIGURE 38     NORTH AMERICA PREFILLED SYRINGES MARKET SHARE, BASED ON DESIGN (2021 V/S 2028) (%)
      • FIGURE 39     NORTH AMERICA PREFILLED SYRINGES MARKET SHARE, BASED ON CLOSURE SYSTEM (2021 V/S 2028) (%)
      • FIGURE 40     NORTH AMERICA PREFILLED SYRINGES MARKET SHARE, BASED ON APPLICATION (2021) (%), CAGR (%)
      • FIGURE 41     NORTH AMERICA PREFILLED SYRINGES MARKET SHARE, BASED ON PRODUCT (2021 V/S 2028) (%)
      • FIGURE 42     NORTH AMERICA COMPLETE PREFILLED SYRINGES MARKET SHARE, BASED ON PRODUCT TYPE (2021 V/S 2028) (%)
      • FIGURE 43     NORTH AMERICA PREFILLED SYRINGES MARKET SHARE, BASED ON ROUTE OF ADMINISTRATION (2021 V/S 2028) (%)
      • FIGURE 44     NORTH AMERICA PREFILLED SYRINGES GLOBAL MARKET SHARE, BASED ON MOLECULE TYPE (2021 V/S 2028) (%)
      • FIGURE 45     NORTH AMERICA PREFILLED SYRINGES GLOBAL MARKET SHARE, BASED ON USABILITY (2021 V/S 2028) (%)
      • FIGURE 46     NORTH AMERICA PREFILLED SYRINGES MARKET SHARE, BASED ON COUNTRY (2021 V/S 2028) (%)
      • FIGURE 47     U.S. PREFILLED SYRINGES MARKET REVENUE BASED ON MATERIAL, DESIGN, MOLECULE TYPE AND USABILITY, (2021 V/S 2028) ($MN)
      • FIGURE 48     U.S. PREFILLED SYRINGES MARKET REVENUE, BASED ON CLOSURE SYSTEM, PRODUCT AND ROUTE OF ADMINISTRATION, (2021 V/S 2028) ($MN)
      • FIGURE 49     U.S. PREFILLED SYRINGES MARKET REVENUE, BASED ON APPLICATION (2021 V/S 2028) ($MN)
      • FIGURE 50     REST OF NORTH AMERICA PREFILLED SYRINGES MARKET REVENUE, BASED ON MATERIAL, DESIGN, MOLECULE TYPE AND USABILITY, (2021 V/S 2028) ($MN)
      • FIGURE 51     REST OF NORTH AMERICA PREFILLED SYRINGES MARKET REVENUE, BASED ON CLOSURE SYSTEM, PRODUCT AND ROUTE OF ADMINISTRATION, (2021 V/S 2028) ($MN)
      • FIGURE 52     REST OF NORTH AMERICA PREFILLED SYRINGES MARKET REVENUE, BASED ON APPLICATION (2021 V/S 2028) ($MN)
      • FIGURE 53     EUROPE PREFILLED SYRINGES MARKET SHARE, BASED ON MATERIAL (2021 V/S 2028) (%)
      • FIGURE 54     EUROPE PREFILLED SYRINGES MARKET SHARE, BASED ON DESIGN, (2021 V/S 2028) (%)
      • FIGURE 55     EUROPE PREFILLED SYRINGES MARKET SHARE, BASED ON CLOSURE SYSTEM (2021 V/S 2028) (%)
      • FIGURE 56     EUROPE PREFILLED SYRINGES MARKET SHARE, BASED ON APPLICATION (2021) (%), CAGR (%)
      • FIGURE 57     EUROPE PREFILLED SYRINGES MARKET SHARE, BASED ON PRODUCT, (2021 V/S 2028) (%)
      • FIGURE 58     EUROPE COMPLETE SYRINGE SYSTEM MARKET SHARE, BASED ON PRODUCT TYPE (2021 V/S 2028) (%)
      • FIGURE 59     EUROPE PREFILLED SYRINGES MARKET SHARE, BASED ON ROUTE OF ADMINISTRATION (2021 V/S 2028) (%)
      • FIGURE 60     EUROPE PREFILLED SYRINGES MARKET SHARE, BASED ON MOLECULE TYPE (2021 V/S 2028) (%)
      • FIGURE 61     EUROPE PREFILLED SYRINGES MARKET SHARE, BASED ON USABILITY (2021 V/S 2028) (%)
      • FIGURE 62     EUROPE PREFILLED SYRINGES MARKET SHARE, BASED ON COUNTRY (2021 V/S 2028) (%)
      • FIGURE 63     GERMANY PREFILLED SYRINGES MARKET REVENUE, BASED ON MATERIAL, DESIGN, MOLECULE TYPE AND USABILITY, (2021 V/S 2028) ($MN)
      • FIGURE 64     GERMANY PREFILLED SYRINGES MARKET REVENUE, BASED ON CLOSURE SYSTEM, PRODUCT, ROUTE OF ADMINISTRATION, (2021 V/S 2028) ($MN)
      • FIGURE 65     GERMANY PREFILLED SYRINGES MARKET REVENUE, BASED ON APPLICATION (2021 V/S 2028) ($MN)
      • FIGURE 66     ITALY PREFILLED SYRINGES MARKET REVENUE, BASED ON MATERIAL, DESIGN, MOLECULE TYPE AND USABILITY (2021 V/S 2028) ($MN)
      • FIGURE 67     ITALY PREFILLED SYRINGES MARKET REVENUE, BASED ON CLOSURE SYSTEM, PRODUCT AND ROUTE OF ADMINISTRATION (2021 V/S 2028) ($MN)
      • FIGURE 68     ITALY PREFILLED SYRINGES MARKET REVENUE, BASED ON APPLICATION (2021 V/S 2028) ($MN)
      • FIGURE 69     FRANCE PREFILLED SYRINGES MARKET REVENUE, BASED ON MATERIAL, DESIGN, MOLECULE TYPE AND USABILITY (2021 V/S 2028) ($MN)
      • FIGURE 70     FRANCE PREFILLED SYRINGES MARKET REVENUE, BASED ON CLOSURE SYSTEM, PRODUCT AND ROUTE OF ADMINISTRATION (2021 V/S 2028) ($MN)
      • FIGURE 71     FRANCE PREFILLED SYRINGES MARKET REVENUE, BASED ON APPLICATION (2021 V/S 2028) ($MN)
      • FIGURE 72     REST OF EUROPE PREFILLED SYRINGES MARKET REVENUE, BASED ON MATERIAL, DESIGN, MOLECULE TYPE AND USABILITY, (2021 V/S 2028) ($MN)
      • FIGURE 73     REST OF EUROPE PREFILLED SYRINGES MARKET REVENUE, BASED ON CLOSURE SYSTEM, PRODUCT AND ROUTE OF ADMINISTRATION, (2021 V/S 2028) ($MN)
      • FIGURE 74     REST OF EUROPE PREFILLED SYRINGES MARKET REVENUE, BASED ON APPLICATION (2021 V/S 2028) ($MN)
      • FIGURE 75     APAC PREFILLED SYRINGES MARKET SHARE, BASED ON MATERIAL (2021 V/S 2028) (%)
      • FIGURE 76     APAC PREFILLED SYRINGES MARKET SHARE, BASED ON DESIGN (2021 V/S 2028) (%)
      • FIGURE 77     APAC PREFILLED SYRINGES MARKET SHARE, BASED ON CLOSURE SYSTEM (2021 V/S 2028) (%)
      • FIGURE 78     APAC PREFILLED SYRINGES MARKET SHARE, BASED ON APPLICATION (2021) (%), CAGR (%)
      • FIGURE 79     APAC PREFILLED SYRINGES MARKET SHARE, BASED ON PRODUCT, (2021 V/S 2028) (%)
      • FIGURE 80     APAC COMPLETE PREFILLED SYRINGE SYSTEM MARKET SHARE, BASED ON PRODUCT TYPE (2021 V/S 2028) (%)
      • FIGURE 81     APAC PREFILLED SYRINGES MARKET SHARE, BASED ON ROUTE OF ADMINISTRATION (2021 V/S 2028) (%)
      • FIGURE 82     APAC PREFILLED SYRINGES GLOBAL MARKET SHARE, BASED ON MOLECULE TYPE (2021 V/S 2028) (%)
      • FIGURE 83     APAC PREFILLED SYRINGES GLOBAL MARKET SHARE, BASED ON USABILITY (2021 V/S 2028) (%)
      • FIGURE 84     APAC PREFILLED SYRINGES MARKET SHARE, BASED ON COUNTRY, (2021 V/S 2028) (%)
      • FIGURE 85     CHINA PREFILLED SYRINGES MARKET REVENUE, BASED ON MATERIAL, DESIGN, MOLECULE TYPE AND USABILITY, (2021 V/S 2028) ($MN)
      • FIGURE 86     CHINA PREFILLED SYRINGES MARKET REVENUE, BASED ON CLOSURE SYSTEM, PRODUCT, ROUTE OF ADMINISTRATION, (2021 V/S 2028) ($MN)
      • FIGURE 87     CHINA PREFILLED SYRINGES MARKET REVENUE, BASED ON APPLICATION (2021 V/S 2028) ($MN)
      • FIGURE 88     JAPAN PREFILLED SYRINGES MARKET REVENUE, BASED ON MATERIAL, DESIGN, MOLECULE TYPE AND USABILITY (2021 V/S 2028) ($MN)
      • FIGURE 89     JAPAN PREFILLED SYRINGES MARKET REVENUE, BASED ON CLOSURE SYSTEM, PRODUCT AND ROUTE OF ADMINISTRATION (2021 V/S 2028) ($MN)
      • FIGURE 90     JAPAN PREFILLED MARKET REVENUE, BASED ON APPLICATION (2021 V/S 2028) ($MN)
      • FIGURE 91     INDIA PREFILLED SYRINGES MARKET REVENUE, BASED ON MATERIAL, DESIGN, MOLECULE TYPE AND USABILITY (2021 V/S 2028) ($MN)
      • FIGURE 92     INDIA PREFILLED SYEINGES MARKET REVENUE, BASED ON CLOSURE SYSTEM, PRODUCT AND ROUTE OF ADMINISTATION, (2021 V/S 2028) ($MN)
      • FIGURE 93     INDIA PREFILLED SYRINHES MARKET REVENUE, BASED ON APPLICATION (2021 V/S 2028) ($MN)
      • FIGURE 94     REST OF APAC PREFILLED SYRINGES MARKET REVENUE, BASED ON MATERIAL, DESIGN, MOLECULE TYPE AND USABILITY, (2021 V/S 2028) ($MN)
      • FIGURE 95     REST OF APAC PREFILLED SYRINGES MARKET REVENUE, BASED ON CLOSURE SYSTEM, PRODUCT AND ROUTE OF ADMINISTRATION, (2021 V/S 2028) ($MN)
      • FIGURE 96     REST OF APAC PREFILLED SYRINGES MARKET REVENUE, BASED ON APPLICATION (2021 V/S 2028) ($MN)
      • FIGURE 97     ROW PREFILLED SYRINGES MARKET SHARE, BASED ON MATERIAL, (2021 V/S 2028) (%)
      • FIGURE 98     ROW PREFILLED SYRINGES MARKET SHARE, BASED ON DESIGN, (2021 V/S 2028) (%)
      • FIGURE 99     ROW PREFILLED SYRINGES MARKET SHARE, BASED ON CLOSURE SYSTEM (2021 V/S 2028) (%)
      • FIGURE 100     ROW PREFILLED SYRINGES MARKET SHARE, BASED ON APPLICATION (2021) (%), CAGR (%)
      • FIGURE 101     ROW PREFILLED SYRINGES MARKET SHARE, BASED ON PRODUCT, (2021 V/S 2028) (%)
      • FIGURE 102     ROW COMPLETE PREFILLED SYRINGES MARKET SHARE, BASED ON PRODUCT TYPE (2021 V/S 2028) (%)
      • FIGURE 103     ROW PREFILLED SYRINGES MARKET SHARE, BASED ON ROUTE OF ADMINISTRATION (2021 V/S 2028) (%)
      • FIGURE 104     ROW PREFILLED SYRINGES GLOBAL MARKET SHARE, BASED ON MOLECULE TYPE (2021 V/S 2028) (%)
      • FIGURE 105     ROW PREFILLED SYRINGES GLOBAL MARKET SHARE, BASED ON USABILITY (2021 V/S 2028) (%)
      • FIGURE 106     ROW PREFILLED SYRINGES MARKET SHARE, BASED ON COUNTRY, (2021 V/S 2028) (%)
      • FIGURE 107     BRAZIL PREFILLED SYRINGES MARKET REVENUE, BASED ON MATERIAL, DESIGN, MOLECULE TYPE AND USABILITY, (2021 V/S 2028) ($MN)
      • FIGURE 108     BRAZIL PREFILLED SYRINGES MARKET REVENUE, BASED ON CLOSURE SYSTEM, PRODUCT, ROUTE OF ADMINISTRATION (2021 V/S 2028) ($MN)
      • FIGURE 109     BRAZIL PREFILLED SYRINGES MARKET REVENUE, BASED ON APPLICATION (2021 V/S 2028) ($MN)
      • FIGURE 110     REST OF LATAM PREFILLED SYRINGES MARKET REVENUE, BASED ON MATERIAL, DESIGN, MOLECULE TYPE AND USABILITY, (2021 V/S 2028) ($MN)
      • FIGURE 111     REST OF LATAM PREFILLED SYRINGES MARKET REVENUE, BASED ON CLOSURE SYSTEM, PRODUCT, ROUTE OF ADMINISTRATION, (2021 V/S 2028) ($MN)
      • FIGURE 112     REST OF LATAM PREFILLED SYRINGES MARKET REVENUE, BASED ON APPLICATION (2021 V/S 2028) ($MN)
      • FIGURE 113     MEA PREFILLED SYRINGES MARKET REVENUE, BASED ON MATERIAL, DESIGN, MOLECULE TYPE AND USABILITY (2021 V/S 2028) ($MN)
      • FIGURE 114     MEA PREFILLED SYRINGES MARKET REVENUE, BASED ON CLOSURE SYSTEM, PRODUCT, ROUTE OF ADMINISTRATION (2021 V/S 2028) ($MN)
      • FIGURE 115     MEA PREFILLED SYRINGES MARKET REVENUE, BASED ON APPLICATION (2021 V/S 2028) ($MN)
      • FIGURE 116     KEY DEVELOPMENTS (2020 –2022)
      • FIGURE 117     SWOT: BECTON, DICKINSON AND COMPANY
      • FIGURE 118     SWOT: ELCAM MEDICAL
      • FIGURE 119     SWOT: GERRESHEIMER AG
      • FIGURE 120     SWOT: NIPRO CORPORATION
      • FIGURE 121     SWOT: OWEN MUMFORD
      • FIGURE 122     SWOT: SCHOTT AG
      • FIGURE 123     SWOT: SHANDONG WEIGAO GROUP MEDICAL POLYMER COMPANY LIMITED
      • FIGURE 124     SWOT: STEVANATO GROUP S.P.A.
      • FIGURE 125     SWOT: TERUMO CORPORATION
      • FIGURE 126     SWOT: YPSOMED HOLDINGS AG

      List of Companies

      • 1     Aguettant Ltd.
      • 2     ApiJect Systems Corp.
      • 3     Arte Corporation
      • 4     Becton, Dickinson And Company
      • 5     Biocorp
      • 6     Congruence Medical Solutions LLC
      • 7     Credence MedSystems Inc.
      • 8     Dali Medical Devices
      • 9     Elcam Medical
      • 10     Gerresheimer AG
      • 11     Hamilton Medical
      • 12     Injecto A/S
      • 13     Jinan Youlyy Industrial Co., Ltd.
      • 14     MEDInstill LLC (Intact Solutions)
      • 15     Merit Medical Systems Inc.
      • 16     Molex (Philips-Medisize)
      • 17     Nemera
      • 18     Nemoto Kyorindo Co., Ltd.
      • 19     Nipro Corporation
      • 20     Owen Mumford LTD
      • 21     Plas-Tech Engineering
      • 22     Recipharm (Bespak)
      • 23     Repro Med Systems, Inc (KORU medical systems)
      • 24     Retractable Technologies, Inc.
      • 25     Roselabs Biosciences Pvt Ltd.
      • 26     Schott AG
      • 27     Shandong Weigao Group Medical Polymer Company Limited
      • 28     Shanghai Kohope Medical Devices Co., Ltd.
      • 29     SHL Medical
      • 30     SMC Ltd.
      • 31     Stevanato Group S.p.A
      • 32     Taisei Kako Co., Ltd.
      • 33     Terumo Corporation
      • 34     Transcoject GmbH
      • 35     Tribofilm Research Inc.
      • 36     Vetter Pharma International GmbH
      • 37     Ypsomed Holding AG